Legal & General Group
PGEN icon

Legal & General Group’s Precigen PGEN Stock Holding History

Legal & General Group’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Buy
128,048
+2,670
+2% +$11.5K ﹤0.01% 2292
2026
Q1 		$485K Sell
125,378
-21,581
-15% -$88.5K ﹤0.01% 2361
2025
Q4 		$614K Buy
146,959
+130,653
+801% +$506K ﹤0.01% 2355
2025
Q3 		$53.6K Sell
16,306
-209
-1% -$590 ﹤0.01% 2719
2025
Q2 		$23.5K Buy
16,515
+5,597
+51% +$7.95K ﹤0.01% 2945
2025
Q1 		$16.2K Hold
10,918
– – ﹤0.01% 3024
2024
Q4 		$12.2K Hold
10,918
– – ﹤0.01% 3207
2024
Q3 		$10.3K Hold
10,918
– – ﹤0.01% 3265
2024
Q2 		$17.3K Hold
10,918
– – ﹤0.01% 3085
2024
Q1 		$15.8K Hold
10,918
– – ﹤0.01% 3061
2023
Q4 		$14.6K Sell
10,918
-1,770
-14% -$2.08K ﹤0.01% 3150
2023
Q3 		$18K Hold
12,688
– – ﹤0.01% 3078
2023
Q2 		$14.5K Sell
12,688
-10,523
-45% -$12.4K ﹤0.01% 3237
2023
Q1 		$24.6K Sell
23,211
-19,686
-46% -$28.4K ﹤0.01% 3011
2022
Q4 		$65K Hold
42,897
– – ﹤0.01% 2902
2022
Q3 		$92K Sell
42,897
-27,590
-39% -$58.2K ﹤0.01% 2847
2022
Q2 		$94K Buy
70,487
+6,777
+11% +$10.1K ﹤0.01% 2873
2022
Q1 		$135K Hold
63,710
– – ﹤0.01% 2793
2021
Q4 		$236K Buy
63,710
+135
+0.2% +$581 ﹤0.01% 2657
2021
Q3 		$317K Buy
63,575
+18,029
+40% +$104K ﹤0.01% 2550
2021
Q2 		$297K Buy
45,546
+2,399
+6% +$16.8K ﹤0.01% 2443
2021
Q1 		$297K Buy
43,147
+14,902
+53% +$126K ﹤0.01% 2381
2020
Q4 		$288K Hold
28,245
– – ﹤0.01% 2354
2020
Q3 		$98K Sell
28,245
-2,959
-9% -$14K ﹤0.01% 2498
2020
Q2 		$155K Buy
31,204
+228
+0.7% +$776 ﹤0.01% 2413
2020
Q1 		$105K Sell
30,976
-2,208
-7% -$9.53K ﹤0.01% 2396
2019
Q4 		$181K Buy
33,184
+733
+2% +$4.13K ﹤0.01% 2417
2019
Q3 		$185K Buy
32,451
+2,377
+8% +$16.2K ﹤0.01% 2364
2019
Q2 		$230K Hold
30,074
– – ﹤0.01% 2315
2019
Q1 		$158K Buy
30,074
+706
+2% +$4.89K ﹤0.01% 2374
2018
Q4 		$192K Buy
29,368
+2,709
+10% +$30.4K ﹤0.01% 2314
2018
Q3 		$459K Buy
26,659
+689
+3% +$10.2K ﹤0.01% 2160
2018
Q2 		$362K Sell
25,970
-4,040
-13% -$68.2K ﹤0.01% 2178
2018
Q1 		$460K Hold
30,010
– – ﹤0.01% 2129
2017
Q4 		$346K Buy
30,010
+11,167
+59% +$166K ﹤0.01% 2180
2017
Q3 		$358K Hold
18,843
– – ﹤0.01% 2166
2017
Q2 		$454K Buy
18,843
+393
+2% +$8.62K ﹤0.01% 2072
2017
Q1 		$365K Buy
18,450
+9,258
+101% +$207K ﹤0.01% 2108
2016
Q4 		$221K Buy
9,192
+858
+10% +$23.9K ﹤0.01% 2209
2016
Q3 		$232K Buy
8,334
+2,463
+42% +$65.1K ﹤0.01% 1994
2016
Q2 		$144K Buy
5,871
+2,049
+54% +$58.1K ﹤0.01% 1903
2016
Q1 		$128K Buy
3,822
+127
+3% +$4K ﹤0.01% 1909
2015
Q4 		$110K Buy
3,695
+1,137
+44% +$38.3K ﹤0.01% 2019
2015
Q3 		$81K Buy
+2,558
New +$125K ﹤0.01% 2161
2015
Q2 		– Sell
-5,771
Closed -$254K – 2780
2015
Q1 		$254K Hold
5,771
– – ﹤0.01% 1576
2014
Q4 		$153K Hold
5,771
– – ﹤0.01% 1725
2014
Q3 		$107K Buy
+5,771
New +$118K ﹤0.01% 1844

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Legal & General Group's PGEN Position: Q2 2026 in Review

Legal & General Group increased its Precigen (PGEN) stake by 2.1% in Q2 2026, buying an estimated $11.5K and bringing the position to 128,048 shares worth $730K. The position accounts for ﹤0.01% of the portfolio, ranked #2292.

Legal & General Group first reported a position in PGEN in Q3 2014 and has held it in 47 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Legal & General Group held 128,048 shares of Precigen worth $730K as of Q2 2026.
  • Legal & General Group bought 2,670 Precigen shares in Q2 2026, an estimated $11.5K.
  • Precigen made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2292 holding.
  • Legal & General Group first reported a position in Precigen in Q3 2014 and has held it in 47 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.